 A vial of Covivac, Vietnam's second COVID-19 vaccine, January 2021. (Photo: VnExpress) |
Covivac, the second Vietnamese-made vaccine to be tested on humans after Nanogen Pharmaceutical Biotechnology’s Nanocovax, had received approval in late January.
The trial would take place at the Hanoi Medical University with 120 volunteers aged 18-59 and without underlying health conditions, infectious diseases or allergies getting two doses or a placebo 28 days apart.
The second phase will begin in July and the final phase in November. Pre-clinical studies in India, the US, and Vietnam have shown that Covivac is safe and effective, Minister of Health Nguyen Thanh Long said.
A dose of the vaccine, which has proven effective against the new variants from the UK and South Africa, would cost around 60,000 VND (2.6 USD).